EntryPoint Capital’s Lifestance Health LFST Stock Holding History

EntryPoint Capital’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$581K	Sell	54,236 -68,694	-56%	-$531K	0.14%	267
2026 Q1	$783K	Buy	122,930 +101,005	+461%	+$703K	0.23%	103
2025 Q4	$154K	Sell	21,925 -94,838	-81%	-$572K	0.06%	587
2025 Q3	$642K	Buy	116,763 +13,114	+13%	+$64.3K	0.25%	92
2025 Q2	$536K	Buy	103,649 +16,058	+18%	+$96.2K	0.27%	72
2025 Q1	$583K	Buy	87,591 +55,382	+172%	+$421K	0.27%	62
2024 Q4	$237K	Buy	+32,209	New	+$231K	0.1%	507
2024 Q3	–	Sell	-8,460	Closed	-$41.5K	–	1021
2024 Q2	$41.5K	Buy	+8,460	New	+$51K	0.02%	1120

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

EntryPoint Capital's LFST Position: Q2 2026 in Review

EntryPoint Capital reduced its Lifestance Health (LFST) stake by 56% in Q2 2026, selling an estimated $531K and leaving 54,236 shares worth $581K. The position accounts for 0.14% of the portfolio, ranked #267.

EntryPoint Capital first reported a position in LFST in Q2 2024 and has held it in 8 quarters since. The position peaked at $783K in Q1 2026. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

EntryPoint Capital held 54,236 shares of Lifestance Health worth $581K as of Q2 2026.
EntryPoint Capital sold 68,694 Lifestance Health shares in Q2 2026, an estimated $531K.
Lifestance Health made up 0.14% of EntryPoint Capital's portfolio in Q2 2026, its #267 holding.
EntryPoint Capital first reported a position in Lifestance Health in Q2 2024 and has held it in 8 quarters since.
EntryPoint Capital's Lifestance Health position peaked at $783K in Q1 2026.
287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.